The role of combination therapy with corticosteroids and long-acting beta2-agonists in the prevention of exacerbations in COPD.
Journal Information
Full Title: Int J Chron Obstruct Pulmon Dis
Abbreviation: Int J Chron Obstruct Pulmon Dis
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Pulmonary Medicine
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Disclosures: Dr Cazzola has received financial support for research and attending meetings and fees for speaking and consulting from Abbott, Altana, AstraZeneca, Boerhinger Ingelheim, Chiesi Farmaceutici, GSK, Meda, Menarini Farmaceutici, Novartis, Pfizer, and Valeas. Dr Hanania has received research grant support from GSK, Boerhinger Ingelheim, AstraZeneca, Dey, Sepracor, and Altana and has served on the advisory board for GSK and Dey. No funding source had any role in the preparation of this paper."
"Disclosures: Dr Cazzola has received financial support for research and attending meetings and fees for speaking and consulting from Abbott, Altana, AstraZeneca, Boerhinger Ingelheim, Chiesi Farmaceutici, GSK, Meda, Menarini Farmaceutici, Novartis, Pfizer, and Valeas. Dr Hanania has received research grant support from GSK, Boerhinger Ingelheim, AstraZeneca, Dey, Sepracor, and Altana and has served on the advisory board for GSK and Dey. No funding source had any role in the preparation of this paper."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025